JP Stock MarketDetailed Quotes
4893 Noile-Immune Biotech
- 174
- 00.00%
20min DelayMarket Closed Nov 27 15:30 JST
7.53BMarket Cap-6385P/E (Static)
175High170Low211.70KVolume174Open174Pre Close36.54MTurnover35352wk High1.59%Turnover Ratio43.30MShares12152wk Low-22.01EPS TTM2.32BFloat Cap775Historical HighLossP/E (Static)13.36MShs Float121Historical Low-27.25EPS LYR2.87%Amplitude--Dividend TTM1.50P/B100Lot Size--Div YieldTTM
Noile-Immune Biotech Key Stats
EPS
According to the latest financial report of Noile-Immune Biotech, the latest earnings per share (TTM) for the company is -7.93. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about Noile-Immune Biotech's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Noile-Immune Biotech shows that the company's current ratio is 66.55, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Noile-Immune Biotech, the quick ratio is 65.05, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of Noile-Immune Biotech? The latest ROE figure is -6.63%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Noile-Immune Biotech, the total asset return on investment (ROA) is -6.51%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Noile-Immune Biotech's latest financial report to see how their gross margin is doing - currently at 92.46%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Noile-Immune Biotech, the net profit margin is -13.15K%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data